The system, which will be installed in Chengdu in the Sichuan province, will be configured with three gantry rooms and one fixed-beam room, according to the vendor. All treatment rooms will be equipped with cone-beam CT capability and pencil-beam scanning for intensity-modulated proton treatments (IMPT), IBA said. The company will also be including its dosimetry software suite.

IBA has valued the contract at 50 million euros ($59.5 million U.S.). Installation is expected to begin in 2022.